MiMedx Group, Inc. provided net sales guidance for the fourth quarter and full year 2022. For the quarter, the company expects net sales to be in a range of $73 to $76 million, which reflects year over year growth in a range of 8% to 15%.

For the full year 2022, the Company expects net sales to be in a range of $266 to $269 million, which reflects 11% to 12% growth on its 2021 net sales of its continuing portfolio of Advanced Wound Care products.